NO992186D0 - System med forsinket avlevering for syresensitive medikamenter - Google Patents

System med forsinket avlevering for syresensitive medikamenter

Info

Publication number
NO992186D0
NO992186D0 NO992186A NO992186A NO992186D0 NO 992186 D0 NO992186 D0 NO 992186D0 NO 992186 A NO992186 A NO 992186A NO 992186 A NO992186 A NO 992186A NO 992186 D0 NO992186 D0 NO 992186D0
Authority
NO
Norway
Prior art keywords
delivery system
acid
barrier
omeprazole
pulsatile
Prior art date
Application number
NO992186A
Other languages
English (en)
Norwegian (no)
Other versions
NO992186L (no
Inventor
Vinay K Sharma
Original Assignee
Sharmatek Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sharmatek Inc filed Critical Sharmatek Inc
Publication of NO992186L publication Critical patent/NO992186L/no
Publication of NO992186D0 publication Critical patent/NO992186D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO992186A 1996-11-06 1999-05-05 System med forsinket avlevering for syresensitive medikamenter NO992186D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74098196A 1996-11-06 1996-11-06
PCT/US1997/020851 WO1998019668A1 (en) 1996-11-06 1997-11-05 Delayed delivery system for acid-sensitive drugs

Publications (2)

Publication Number Publication Date
NO992186L NO992186L (no) 1999-05-05
NO992186D0 true NO992186D0 (no) 1999-05-05

Family

ID=24978866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992186A NO992186D0 (no) 1996-11-06 1999-05-05 System med forsinket avlevering for syresensitive medikamenter

Country Status (7)

Country Link
EP (1) EP0941074B1 (de)
AT (1) ATE271379T1 (de)
AU (1) AU5179898A (de)
DE (1) DE69729950T2 (de)
NO (1) NO992186D0 (de)
WO (1) WO1998019668A1 (de)
ZA (1) ZA979937B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2774288B1 (fr) 1998-01-30 2001-09-07 Ethypharm Sa Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques
FR2793688B1 (fr) 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
SE9902386D0 (sv) * 1999-06-22 1999-06-22 Astra Ab New formulation
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
DE19959419A1 (de) 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
ATE297194T1 (de) * 1999-12-16 2005-06-15 Medinfar Produtos Farmaceutico Neue stabile mehreinheitliche substituierte benzimidazole enthaltende pharmazeutische präparate
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
JP4551089B2 (ja) * 2001-10-29 2010-09-22 マサチューセッツ インスティテュート オブ テクノロジー 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム
US8168170B2 (en) 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
EP1602362B1 (de) * 2003-03-12 2016-09-28 Takeda Pharmaceutical Company Limited Arzneimittelzusammensetzung mit wirkstoff, der in hoher konzentration an einem kugelförmigen kern anhaftet
WO2005051362A2 (en) * 2003-11-28 2005-06-09 Ranbaxy Laboratories Limited Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050214372A1 (en) * 2004-03-03 2005-09-29 Simona Di Capua Stable pharmaceutical composition comprising an acid labile drug
WO2006002077A2 (en) * 2004-06-15 2006-01-05 Teva Pharmaceutical Industries Ltd. Stable pharmaceutical formulations of benzimidazole compounds
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
AR052225A1 (es) * 2004-11-04 2007-03-07 Astrazeneca Ab Formulaciones de tabletas de liberacion modificada par inhibidores de la bomba de protones
US8227476B2 (en) 2005-08-03 2012-07-24 Sprout Pharmaceuticals, Inc. Use of flibanserin in the treatment of obesity
JP2009513604A (ja) 2005-10-29 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
CN101389316A (zh) * 2005-12-28 2009-03-18 武田药品工业株式会社 控制释放固体制剂
CN101389317A (zh) * 2005-12-28 2009-03-18 武田药品工业株式会社 控制释放固体制剂
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
KR20090042967A (ko) 2006-08-14 2009-05-04 베링거 인겔하임 인터내셔날 게엠베하 플리반세린 제형 및 이의 제조방법
AR062321A1 (es) * 2006-08-25 2008-10-29 Boehringer Ingelheim Int Sistema de liberacion controlada y metodo para fabricarlo
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
PE20091188A1 (es) 2007-09-12 2009-08-31 Boehringer Ingelheim Int Compuesto 1-[2-(4-(3-trifluorometil-fenil)piperazin-1-il)etil]-2,3-dihidro-1h-benzimidazol-2-ona (flibanserina), sus sales de adicion y composiciones farmaceuticas que los contienen
WO2009113090A2 (en) * 2008-01-17 2009-09-17 Alkem Laboratories Ltd. Process for preparing an oral formulation of an acid-sensitive benzimidazole drug
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CA2686480A1 (en) 2008-12-15 2010-06-15 Boehringer Ingelheim International Gmbh New salts
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
EP0723436B1 (de) * 1994-07-08 2001-09-26 AstraZeneca AB Aus mehreren einzeleinheiten zusammengesetzte dosierungsform in tablettenform (i)

Also Published As

Publication number Publication date
EP0941074B1 (de) 2004-07-21
ATE271379T1 (de) 2004-08-15
ZA979937B (en) 1999-05-18
EP0941074A1 (de) 1999-09-15
DE69729950D1 (de) 2004-08-26
DE69729950T2 (de) 2005-07-28
AU5179898A (en) 1998-05-29
NO992186L (no) 1999-05-05
WO1998019668A1 (en) 1998-05-14

Similar Documents

Publication Publication Date Title
NO992186D0 (no) System med forsinket avlevering for syresensitive medikamenter
AU1488295A (en) Pharmaceutical composition
DE60021604D1 (de) Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
NO982302L (no) Farmas°ytisk sammensetning
PT1117386E (pt) Administracao enterica e colonica utilizando capsulas de hpmc
NZ237516A (en) Device for drug delivery to intestinal tract comprising a core of active ingredient together with osmotically activated expulsion agent and an outer coating containing a hydrophobic material to assist in delaying release
MX9500885A (es) Preparacion farmaceutica para administracion oral.
NO20003640L (no) Ny doseringsform
RU99126869A (ru) Фармацевтический препарат омепразола
IT1246382B (it) Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
NZ711298A (en) Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
DK0754452T3 (da) Farmaceutisk præparat i form af en overtrukket kapsel, der frigives i den nedre del af fordøjelsessystemet
US5824341A (en) Composition providing selective release of an active ingredient
MXPA05001243A (es) Formulacion de lamotrigina de liberacion prolongada y uso de la misma para su preparacion.
WO2001024777A1 (en) Coated solid dosage forms
CA2304135C (en) Medicament formulation with a controlled release of an active agent
KR20220113697A (ko) 알칼리제 및 장용성 코팅층을 포함하는 투여 형태
WO2001078681A1 (fr) Systeme d'administration de medicament empechant l'interaction pharmacocinetique entre les medicaments et procede correspondant
AU2009247712C1 (en) Compositions and methods for inhibiting gastric acid secretion
AU2020330542A1 (en) Articles and methods for administration of therapeutic agents
US20060043207A1 (en) Apparatus, kit and related methods for administering substances
US6074669A (en) Controlled drug delivery system for diltiazem
AU2014239683A1 (en) Mesalamine pharmaceutical composition with multiple dosage elements for reduced delivery variability
WO2004041244A2 (en) Oral extended release tablets and methods of making and using the same
JPH06256166A (ja) 薬物放出制御製剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application